Dosidal · Switzerland
Reblozyl, Pulver zur Herstellung einer Injektionslösung
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:69592 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 69592 atc: B03XA06 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2026-05-21 term: zugelassen valid_until: 2031-05-20 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: B03XA06 authorisation_number: 69592 form: PULVL holder: Bristol-Myers Squibb SA holder_partner_nr: 1100488 it_number: 06.07.3. name: Reblozyl, Pulver zur Herstellung einer Injektionslösung state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53MTr5G8Vwtzt-bs3QyC7SENffkF1SHUCjxZtbmAgx4kp5edfoKXmuzl65P-fdmAJVDklZjl12BYR9tU_brCz27gVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |